Zhejiang Tailin Bioengineering Co Ltd
Zhejiang Tailin BioEngineering Co.,Ltd offers life science system solutions in China. The company offers cell and gene therapy solutions, including biosafety ferret isolators, sterile pig preparation solutions, aseptic filling workstation, cell preparation workstation, and robotic packaging workstations; drug development and sterile production solutions, comprising sterile packaging, highly activ… Read more
Zhejiang Tailin Bioengineering Co Ltd (300813) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.015x
Based on the latest financial reports, Zhejiang Tailin Bioengineering Co Ltd (300813) has a cash flow conversion efficiency ratio of 0.015x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥11.74 Million) by net assets (CN¥790.14 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zhejiang Tailin Bioengineering Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Zhejiang Tailin Bioengineering Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Zhejiang Tailin Bioengineering Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Tailin Bioengineering Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ROX Resources Ltd
AU:RXL
|
-0.149x |
|
Kumho Industrial Co Ltd
KO:002995
|
-0.083x |
|
REDCENTRIC PLCLS-001
F:6YD
|
N/A |
|
Norske Skog Asa
OL:NSKOG
|
0.039x |
|
COTGF
OTCQX:COTGF
|
N/A |
|
Conduent Inc
NASDAQ:CNDT
|
0.047x |
|
Sports Toto Berhad
KLSE:1562
|
-0.017x |
|
Torpol S.A.
F:9ZE
|
N/A |
Annual Cash Flow Conversion Efficiency for Zhejiang Tailin Bioengineering Co Ltd (2013–2024)
The table below shows the annual cash flow conversion efficiency of Zhejiang Tailin Bioengineering Co Ltd from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥820.73 Million | CN¥24.66 Million | 0.030x | +911.17% |
| 2023-12-31 | CN¥650.24 Million | CN¥1.93 Million | 0.003x | -97.85% |
| 2022-12-31 | CN¥647.45 Million | CN¥89.39 Million | 0.138x | +90.94% |
| 2021-12-31 | CN¥497.38 Million | CN¥35.96 Million | 0.072x | -69.78% |
| 2020-12-31 | CN¥444.24 Million | CN¥106.28 Million | 0.239x | +88.75% |
| 2019-12-31 | CN¥229.11 Million | CN¥29.04 Million | 0.127x | -33.89% |
| 2018-12-31 | CN¥194.70 Million | CN¥37.33 Million | 0.192x | +21.87% |
| 2017-12-31 | CN¥146.48 Million | CN¥23.04 Million | 0.157x | -42.03% |
| 2016-12-31 | CN¥116.31 Million | CN¥31.56 Million | 0.271x | +7.74% |
| 2015-12-31 | CN¥97.42 Million | CN¥24.54 Million | 0.252x | -20.82% |
| 2014-12-31 | CN¥55.04 Million | CN¥17.51 Million | 0.318x | +79.38% |
| 2013-12-31 | CN¥64.92 Million | CN¥11.51 Million | 0.177x | -- |